Fortis Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-225
| Closed | -$9.18K | – | 206 |
|
|
2023
Q1 | $9.18K | Buy |
225
+2
| +0.9% | +$82 | 0.01% | 208 |
|
|
2022
Q4 | $11.4K | Buy |
223
+2
| +0.9% | +$102 | 0.01% | 204 |
|
|
2022
Q3 | $10K | Buy |
221
+2
| +0.9% | +$90 | 0.01% | 203 |
|
|
2022
Q2 | $11K | Buy |
219
+2
| +0.9% | +$100 | 0.01% | 218 |
|
|
2022
Q1 | $11K | Buy |
217
+1
| +0.5% | +$51 | 0.01% | 232 |
|
|
2021
Q4 | $13K | Buy |
216
+2
| +0.9% | +$120 | 0.01% | 211 |
|
|
2021
Q3 | $9K | Buy |
214
+2
| +0.9% | +$84 | 0.01% | 227 |
|
|
2021
Q2 | $8K | Buy |
212
+2
| +1% | +$75 | ﹤0.01% | 230 |
|
|
2021
Q1 | $8K | Buy |
210
+2
| +1% | +$76 | 0.01% | 198 |
|
|
2020
Q4 | $8K | Sell |
208
-9
| -4% | -$346 | 0.01% | 150 |
|
|
2020
Q3 | $8K | Buy |
217
+2
| +0.9% | +$74 | 0.01% | 131 |
|
|
2020
Q2 | $7K | Buy |
215
+2
| +0.9% | +$65 | 0.01% | 151 |
|
|
2020
Q1 | $7K | Buy |
213
+3
| +1% | +$99 | ﹤0.01% | 276 |
|
|
2019
Q4 | $8K | Buy |
210
+1
| +0.5% | +$38 | ﹤0.01% | 275 |
|
|
2019
Q3 | $7K | Buy |
209
+2
| +1% | +$67 | ﹤0.01% | 280 |
|
|
2019
Q2 | $8K | Buy |
207
+3
| +1% | +$116 | ﹤0.01% | 307 |
|
|
2019
Q1 | $8K | Buy |
204
+2
| +1% | +$78 | ﹤0.01% | 295 |
|
|
2018
Q4 | $8K | Buy |
202
+1
| +0.5% | +$40 | ﹤0.01% | 275 |
|
|
2018
Q3 | $8K | Buy |
201
+2
| +1% | +$80 | ﹤0.01% | 275 |
|
|
2018
Q2 | $7K | Buy |
199
+1
| +0.5% | +$35 | ﹤0.01% | 281 |
|
|
2018
Q1 | $7K | Buy |
198
+2
| +1% | +$71 | ﹤0.01% | 266 |
|
|
2017
Q4 | $7K | Buy |
196
+2
| +1% | +$71 | ﹤0.01% | 244 |
|
|
2017
Q3 | $7K | Buy |
+194
| New | +$7K | ﹤0.01% | 247 |
|